AIM
DXCM icon

Acrospire Investment Management’s DexCom DXCM Stock Holding History

Acrospire Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-400
Closed -$7K – 2074
2016
Q1 		$7K Buy
+400
New +$6.68K ﹤0.01% 1811

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acrospire Investment Management's DXCM Position: Q2 2016 in Review

Acrospire Investment Management sold out of DexCom (DXCM) in Q2 2016, closing a stake of 400 shares — an estimated $7K sold.

Acrospire Investment Management first reported a position in DXCM in Q1 2016 and held it in 1 quarter. The position peaked at $7K in Q1 2016. 279 funds tracked by Wall St. Rank hold DXCM as of Q2 2016.

  • Acrospire Investment Management reported no remaining DexCom position as of Q2 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 400 DexCom shares in Q2 2016, an estimated $7K.
  • Acrospire Investment Management first reported a position in DexCom in Q1 2016 and held it in 1 quarter.
  • Acrospire Investment Management's DexCom position peaked at $7K in Q1 2016.
  • 279 funds tracked by Wall St. Rank held DexCom as of Q2 2016.

Based on Acrospire Investment Management's 13F filing for Q2 2016, filed 9 Aug 2016.